The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
The global Insulin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Insulin in various end use industries.
The expanding demands from the Short Acting, Intermediate Acting, Long Acting and Pre-Mix Insulin, are propelling Insulin market. Animal Insulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Regular Human Insulin segment is estimated at % CAGR for the next seven-year period.
The major players in China Insulin market include Novo Nordisk, Eli Lilly, etc. The top 2 players occupy about 60% shares of the whole market. Tianjin and Jiangsu are main markets, they occupy about 60% of the whole market. Regular Human Insulin is the main type, with a share over 60%. Long Acting and Intermediate Acting are the main applications, which holds a share about 70%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin covered in this report include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Tonghua Dongbao, Ganlee, United Laboratory and Jiangsu Wanbang, etc.
The global Insulin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Novo Nordisk
- Eli Lilly
- Sanofi-Aventis
- Tonghua Dongbao
- Ganlee
- United Laboratory
- Jiangsu Wanbang
Global Insulin market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin market, Segment by Type:
- Animal Insulin
- Regular Human Insulin
- Insulin Analogue
Global Insulin market, by Application
- Short Acting
- Intermediate Acting
- Long Acting
- Pre-Mix Insulin
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.Chapter Two: Detailed analysis of Insulin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Insulin Market Overview
1.1 Insulin Product Overview
1.2 Insulin Market Segment by Type
1.2.1 Animal Insulin
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Global Insulin Market Size by Type
1.3.1 Global Insulin Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Sales Breakdown by Type (2018-2023)
2 Global Insulin Market Competition by Company
2.1 Global Top Players by Insulin Sales (2018-2023)
2.2 Global Top Players by Insulin Revenue (2018-2023)
2.3 Global Top Players by Insulin Price (2018-2023)
2.4 Global Top Manufacturers Insulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Market Competitive Situation and Trends
2.5.1 Insulin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Market
2.8 Key Manufacturers Insulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Status and Outlook by Region
3.1 Global Insulin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Historic Market Size by Region
3.2.1 Global Insulin Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Forecasted Market Size by Region
3.3.1 Global Insulin Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin by Application
4.1 Insulin Market Segment by Application
4.1.1 Short Acting
4.1.2 Intermediate Acting
4.1.3 Long Acting
4.1.4 Pre-Mix Insulin
4.2 Global Insulin Market Size by Application
4.2.1 Global Insulin Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Sales Breakdown by Application (2018-2023)
5 North America Insulin by Country
5.1 North America Insulin Historic Market Size by Country
5.1.1 North America Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Sales in Value by Country (2018-2023)
5.2 North America Insulin Forecasted Market Size by Country
5.2.1 North America Insulin Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Sales in Value by Country (2024-2029)
6 Europe Insulin by Country
6.1 Europe Insulin Historic Market Size by Country
6.1.1 Europe Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Sales in Value by Country (2018-2023)
6.2 Europe Insulin Forecasted Market Size by Country
6.2.1 Europe Insulin Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin by Region
7.1 Asia-Pacific Insulin Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Sales in Value by Region (2024-2029)
8 Latin America Insulin by Country
8.1 Latin America Insulin Historic Market Size by Country
8.1.1 Latin America Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Forecasted Market Size by Country
8.2.1 Latin America Insulin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin by Country
9.1 Middle East and Africa Insulin Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Insulin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Insulin Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Eli Lilly
10.2.1 Eli Lilly Company Information
10.2.2 Eli Lilly Introduction and Business Overview
10.2.3 Eli Lilly Insulin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eli Lilly Insulin Products Offered
10.2.5 Eli Lilly Recent Development
10.3 Sanofi-Aventis
10.3.1 Sanofi-Aventis Company Information
10.3.2 Sanofi-Aventis Introduction and Business Overview
10.3.3 Sanofi-Aventis Insulin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi-Aventis Insulin Products Offered
10.3.5 Sanofi-Aventis Recent Development
10.4 Tonghua Dongbao
10.4.1 Tonghua Dongbao Company Information
10.4.2 Tonghua Dongbao Introduction and Business Overview
10.4.3 Tonghua Dongbao Insulin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Tonghua Dongbao Insulin Products Offered
10.4.5 Tonghua Dongbao Recent Development
10.5 Ganlee
10.5.1 Ganlee Company Information
10.5.2 Ganlee Introduction and Business Overview
10.5.3 Ganlee Insulin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ganlee Insulin Products Offered
10.5.5 Ganlee Recent Development
10.6 United Laboratory
10.6.1 United Laboratory Company Information
10.6.2 United Laboratory Introduction and Business Overview
10.6.3 United Laboratory Insulin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 United Laboratory Insulin Products Offered
10.6.5 United Laboratory Recent Development
10.7 Jiangsu Wanbang
10.7.1 Jiangsu Wanbang Company Information
10.7.2 Jiangsu Wanbang Introduction and Business Overview
10.7.3 Jiangsu Wanbang Insulin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Jiangsu Wanbang Insulin Products Offered
10.7.5 Jiangsu Wanbang Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Industrial Chain Analysis
11.4 Insulin Market Dynamics
11.4.1 Insulin Industry Trends
11.4.2 Insulin Market Drivers
11.4.3 Insulin Market Challenges
11.4.4 Insulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Distributors
12.3 Insulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
